Immunology and bone

Journal of Biochemistry

Volumn 154, Issue 1, 2013, Pages 29-39

  Danks, Lynett ^a   Takayanagi, Hiroshi ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

haematopoietic stem cell; osteoblast; osteoclast; RANKL; T cell

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCITONIN RECEPTOR; CATHEPSIN K; CD40 LIGAND; EPIDERMAL GROWTH FACTOR RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TRANSCRIPTION FACTOR NFAT3; TRANSCRIPTION FACTOR NFAT3C1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

BONE; BONE CELL; BONE DENSITY; BONE METABOLISM; CALCIUM SIGNALING; CELL SURVIVAL; DENDRITIC CELL; ENTERITIS; HUMORAL IMMUNITY; IMMUNOLOGY; IMMUNOMODULATION; METABOLIC REGULATION; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH17 CELL;

HAEMATOPOIETIC STEM CELL; OSTEOBLAST; OSTEOCLAST; RANKL; T CELL;

ANIMALS; ARTHRITIS, RHEUMATOID; BONE AND BONES; CALCIUM SIGNALING; FEMALE; HUMANS; MALE; MICE; MODELS, BIOLOGICAL; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SIGNAL TRANSDUCTION; STEM CELL NICHE; T-LYMPHOCYTE SUBSETS;

MUS;

EID: 84879891819     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvt049     Document Type: Review

References (86)

1. Nakashima, T., Hayashi, M., and Takayanagi, H. (2012) New insights into osteoclastogenic signaling mechan-isms. Trends Endocrinol. Metab. 23, 582-590
2. Hardy, R. and Cooper, M.S. (2009) Bone loss in inflam-matory disorders. J. Endocrinol. 201, 309-320
3. Takayanagi, H. (2007) Osteoimmunology: shared mech-anisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7, 292-304 (Pubitemid 46480961)
4. Lorenzo, J., Horowitz, M., and Choi, Y. (2008) Osteoimmunology: interactions of the bone and immune system. Endocr. Rev. 29, 403-440 (Pubitemid 351831507)
5. Komatsu, N. and Takayanagi, H. (2012) Autoimmune arthritis: the interface between the immune system and joints. Adv. Immunol. 115, 45-71
6. Lacey, D.L., Timms, E., Tan, H.L., Kelley, M.J., Dunstan, C.R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., Hsu, H., Sullivan, J., Hawkins, N., Davy, E., Capparelli, C., Eli, A., Qian, Y.X., Kaufman, S., Sarosi, I., Shalhoub, V., Senaldi, G., Guo, J., Delaney, J., and Boyle, W.J. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differenti-ation and activation. Cell 93, 165-176 (Pubitemid 28180851)
7. Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K., Udagawa, N., Takahashi, N., and Suda, T. (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl Acad. Sci. U. S. A. 95, 3597-3602
8. Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M.T., and Martin, T.J. (1999) Modulation of osteoclast differentiation and function by the new mem-bers of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20, 345-357 (Pubitemid 30649812)
9. Simonet, W.S., Lacey, D.L., Dunstan, C.R., Kelley, M., Chang, M.S., Luthy, R., Nguyen, H.Q., Wooden, S., Bennett, L., Boone, T., Shimamoto, G., De Rose, M., Elliott, R., Colombero, A., Tan, H.L., Trail, G., Sullivan, J., Davy, E., Bucay, N., Renshaw-Gegg, L., Hughes, T.M., Hill, D., Pattison, W., Campbell, P., Sander, S., Van, G., Tarpley, J., Derby, P., Lee, R., and Boyle, W.J. (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89, 309-319 (Pubitemid 27199902)
10. Kong, Y.Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., Mc Cabe, S., Wong, T., Campagnuolo, G., Moran, E., Bogoch, E.R., Van, G., Nguyen, L.T., Ohashi, P.S., Lacey, D.L., Fish, E., Boyle, W.J., and Penninger, J.M. (1999) Activated T cells regulate bone loss andjoint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402, 304-309 (Pubitemid 129516268)
11. Mc Clung, M.R., Lewiecki, E.M., Cohen, S.B., Bolognese, M.A., Woodson, G.C., Moffett, A.H., Peacock, M., Miller, P.D., Lederman, S.N., Chesnut, C.H., Lain, D., Kivitz, A.J., Holloway, D.L., Zhang, C., Peterson, M.C., and Bekker, P.J. (2006) Denosumab in postmenopausal women with low bone mineral density. N. Engl. J. Med. 354, 821-831 (Pubitemid 43290920)
12. Lacey, D.L., Boyle, W.J., Simonet, W.S., Kostenuik, P.J., Dougall, W.C., Sullivan, J.K., San Martin, J., and Dansey, R. (2012) Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the devel-opment of denosumab. Nat. Rev. Drug Discov. 11, 401-419
13. Wong, B.R., Rho, J., Arron, J., Robinson, E., Orlinick, J., Chao, M., Kalachikov, S., Cayani, E., Bartlett, F.S. 3rd, Frankel, W.N., Lee, S.Y., and Choi, Y. (1997) TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272, 25190-25194 (Pubitemid 27415705)
14. Anderson, D.M., Maraskovsky, E., Billingsley, W.L., Dougall, W.C., Tometsko, M.E., Roux, E.R., Teepe, M.C., Du Bose, R.F., Cosman, D., and Galibert, L. (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390, 175-179 (Pubitemid 27507987)
15. Bachmann, M.F., Wong, B.R., Josien, R., Steinman, R.M., Oxenius, A., and Choi, Y. (1999) TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation. J. Exp. Med. 189, 1025-1031 (Pubitemid 29169819)
16. Desanti, G.E., Cowan, J.E., Baik, S., Parnell, S.M., White, A.J., Penninger, J.M., Lane, P.J., Jenkinson, E.J., Jenkinson, W.E., and Anderson, G (2012) Developmentally regulated availability of RANKL and CD40 ligand reveals distinct mechanisms of fetal and adult cross-talk in the thymus medulla. J. Immunol. 189, 5519-5526
17. Anderson, M.S., Venanzi, E.S., Klein, L., Chen, Z., Berzins, S.P., Turley, S.J., von Boehmer, H., Bronson, R., Dierich, A., Benoist, C., and Mathis, D. (2002) Projection of an immunological self shadow within the thymus by the aire protein. Science 298, 1395-1401 (Pubitemid 35346134)
18. Loser, K., Mehling, A., Loeser, S., Apelt, J., Kuhn, A., Grabbe, S., Schwarz, T., Penninger, J.M., and Beissert, S. (2006) Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat. Med. 12, 1372-1379 (Pubitemid 44924495)
19. Aschenbrenner, K., D'Cruz, L.M., Vollmann, E.H., Hinterberger, M., Emmerich, J., Swee, L.K., Rolink, A., and Klein, L. (2007) Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nat. Immunol. 8, 351-358 (Pubitemid 46745410)
20. Rossi, S.W., Kim, M.Y., Leibbrandt, A., Parnell, S.M., Jenkinson, W.E., Glanville, S.H., Mc Connell, F.M., Scott, H.S., Penninger, J.M., Jenkinson, E.J., Lane, P.J., and Anderson, G (2007) RANK signals from CD4(+)3(-) inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla. J. Exp. Med. 204, 1267-1272 (Pubitemid 46919863)
21. Kong, Y.Y., Yoshida, H., Sarosi, I., Tan, H.L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A.J., Van, G., Itie, A., Khoo, W., Wakeham, A., Dunstan, C.R., Lacey, D.L., Mak, T.W., Boyle, W.J., and Penninger, J.M. (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315-323
22. Moschen, A.R., Kaser, A., Enrich, B., Ludwiczek, O., Gabriel, M., Obrist, P., Wolf, A.M., and Tilg, H. (2005) The RANKL/OPG system is activated in inflam-matory bowel disease and relates to the state of bone loss. Gut 54, 479-487 (Pubitemid 40395499)
23. Ashcroft, A.J., Cruickshank, S.M., Croucher, P.I., Perry, M.J., Rollinson, S., Lippitt, J.M., Child, J.A., Dunstan, C., Felsburg, P.J., Morgan, G.J., and Carding, S.R. (2003) Colonic dendritic cells, intestinal inflamma-tion, and T cell-mediated bone destruction are modu-lated by recombinant osteoprotegerin. Immunity 19, 849-861 (Pubitemid 37542305)
24. Xu, D., Wang, S., Liu, W., Liu, J., and Feng, X. (2006) A novel receptor activator of NF-kappa B (RANK) cytoplasmic motif plays an essential role in osteoclasto-genesis by committing macrophages to the osteoclast lineage. J. Biol. Chem. 281, 4678-4690 (Pubitemid 43847727)
25. Kim, H., Choi, H.K., Shin, J.H., Kim, K.H., Huh, J.Y., Lee, S.A., Ko, C.Y., Kim, H.S., Shin, H.I., Lee, H.J., Jeong, D., Kim, N., Choi, Y., and Lee, S.Y. (2009) Selective inhibition of RANK blocks osteoclast matur-ation and function and prevents bone loss in mice. J. Clin. Invest. 119, 813-825
26. Wada, T., Nakashima, T., Oliveira-dos-Santos, A.J., Gasser, J., Hara, H., Schett, G., and Penninger, J.M. (2005) The molecular scaffold Gab2 is a crucial compo-nent of RANK signaling and osteoclastogenesis. Nat. Med. 11, 394-399 (Pubitemid 40562329)
27. Yi, T., Lee, H.L., Cha, J.H., Ko, S.I., Kim, H.J., Shin, H.I., Woo, K.M., Ryoo, H.M., Kim, G.S., and Baek, J.H. (2008) Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling. J. Cell. Physiol. 217, 409-422
28. Bai, S., Kitaura, H., Zhao, H., Chen, J., Muller, J.M., Schule, R., Darnay, B., Novack, D.V., Ross, F.P., and Teitelbaum, S.L. (2005) FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner. J. Clin. Invest. 115, 2742-2751 (Pubitemid 41434401)
29. Kim, H.J., Zhang, K., Zhang, L., Ross, F.P., Teitelbaum, S.L., and Faccio, R. (2009) The Src fam-ily kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo. Proc. Natl Acad. Sci. U. S. A. 106, 2325-2330
30. Jin, W., Chang, M., Paul, E.M., Babu, G., Lee, A.J., Reiley, W., Wright, A., Zhang, M., You, J., and Sun, S.C. (2008) Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice. J. Clin. Invest. 118, 1858-1866 (Pubitemid 351632388)
31. Maruyama, K., Kawagoe, T., Kondo, T., Akira, S., and Takeuchi, O. (2012) TRAF family member-associated NF-kappa B activator (TANK) is a negative regulator of osteoclastogenesis and bone formation. J. Biol. Chem. 287, 29114-29124
32. Lorenzo, T.C.Y., Horowitz, M., Choi, Y., and Takayanagi, H. (2010) Osteoimmunology: Interactions of the Immune and Skeletal Systems. Academic Press, Burlington, MA
33. Franzoso, G., Carlson, L., Xing, L., Poljak, L., Shores, E.W., Brown, K.D., Leonardi, A., Tran, T., Boyce, B.F., and Siebenlist, U. (1997) Requirement for NF-kappa B in osteoclast and B-cell development. Genes Dev. 11, 3482-3496 (Pubitemid 28023969)
34. Ruocco, M.G., Maeda, S., Park, J.M., Lawrence, T., Hsu, L.C., Cao, Y., Schett, G., Wagner, E.F., and Karin, M. (2005) I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss. J. Exp. Med. 201, 1677-1687 (Pubitemid 40721011)
35. Jimi, E., Aoki, K., Saito, H., D'Acquisto, F., May, M.J., Nakamura, I., Sudo, T., Kojima, T., Okamoto, F., Fukushima, H., Okabe, K., Ohya, K., and Ghosh, S. (2004) Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nat. Med. 10, 617-624 (Pubitemid 38796853)
36. Doffinger, R., Smahi, A., Bessia, C., Geissmann, F., Feinberg, J., Durandy, A., Bodemer, C., Kenwrick, S., Dupuis-Girod, S., Blanche, S., Wood, P., Rabia, S.H., Headon, D.J., Overbeek, P.A., Le Deist, F., Holland, S.M., Belani, K., Kumararatne, D.S., Fischer, A., Shapiro, R., Conley, M.E., Reimund, E., Kalhoff, H., Abinun, M., Munnich, A., Israel, A., Courtois, G., and Casanova, J.L. (2001) X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappa B signaling. Nat. Genet. 27, 277-285 (Pubitemid 32201848)
37. Grigoriadis, A.E., Wang, Z.Q., Cecchini, M.G., Hofstetter, W., Felix, R., Fleisch, H.A., and Wagner, E.F. (1994) c-Fos: a key regulator of osteoclast-macro-phage lineage determination and bone remodeling. Science 266, 443-448
38. Faccio, R., Takeshita, S., Zallone, A., Ross, F.P., and Teitelbaum, S.L. (2003) c-Fms and the alphavbeta3 integrin collaborate during osteoclast differentiation. J. Clin. Invest. 111, 749-758 (Pubitemid 36278593)
39. Arai, A., Mizoguchi, T., Harada, S., Kobayashi, Y., Nakamichi, Y., Yasuda, H., Penninger, J.M., Yamada, K., Udagawa, N., and Takahashi, N. (2012) Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment. J. Cell. Sci. 125 (Pt 12), 2910-2917
40. Sato, K., Suematsu, A., Nakashima, T., Takemoto-Kimura, S., Aoki, K., Morishita, Y., Asahara, H., Ohya, K., Yamaguchi, A., Takai, T., Kodama, T., Chatila, T.A., Bito, H., and Takayanagi, H. (2006) Regulation of osteoclast differentiation and function by the Ca MK-CREB pathway. Nat. Med. 12, 1410-1416 (Pubitemid 44924500)
41. Wagner, E.F. and Eferl, R. (2005) Fos/AP-1 proteins in bone and the immune system. Immunol. Rev. 208, 126-140 (Pubitemid 41746389)
42. Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J., Wagner, E.F., Mak, T.W., Kodama, T., and Taniguchi, T. (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteo-clasts. Dev. Cell 3, 889-901 (Pubitemid 35460788)
43. Asagiri, M., Sato, K., Usami, T., Ochi, S., Nishina, H., Yoshida, H., Morita, I., Wagner, E.F., Mak, T.W., Serfling, E., and Takayanagi, H. (2005) Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 202, 1261-1269 (Pubitemid 41586956)
44. Winslow, M.M., Pan, M., Starbuck, M., Gallo, E.M., Deng, L., Karsenty, G., and Crabtree, G.R. (2006) Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Dev. Cell 10, 771-782 (Pubitemid 43779111)
45. Aliprantis, A.O., Ueki, Y., Sulyanto, R., Park, A., Sigrist, K.S., Sharma, S.M., Ostrowski, M.C., Olsen, B.R., and Glimcher, L.H. (2008) NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J. Clin. Invest. 118, 3775-3789
46. Matsuo, K., Galson, D.L., Zhao, C., Peng, L., Laplace, C., Wang, K.Z., Bachler, M.A., Amano, H., Aburatani, H., Ishikawa, H., and Wagner, E.F. (2004) Nuclear factor of activated T-cells (NFAT) rescues osteoclasto-genesis in precursors lacking c-Fos. J. Biol. Chem. 279, 26475-26480 (Pubitemid 38798801)
47. Koga, T., Inui, M., Inoue, K., Kim, S., Suematsu, A., Kobayashi, E., Iwata, T., Ohnishi, H., Matozaki, T., Kodama, T., Taniguchi, T., Takayanagi, H., and Takai, T. (2004) Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428, 758-763 (Pubitemid 38508286)
48. Tomida, T., Hirose, K., Takizawa, A., Shibasaki, F., and Iino, M. (2003) NFAT functions as a working memory of Ca2+ signals in decoding Ca2+ oscillation. EMBO J. 22, 3825-3832 (Pubitemid 36975710)
49. Negishi-Koga, T. and Takayanagi, H. (2009) Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation. Immunol. Rev. 231, 241-256
50. Shinohara, M., Koga, T., Okamoto, K., Sakaguchi, S., Arai, K., Yasuda, H., Takai, T., Kodama, T., Morio, T., Geha, R.S., Kitamura, D., Kurosaki, T., Ellmeier, W., and Takayanagi, H. (2008) Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals. Cell 132, 794-806 (Pubitemid 351312796)
51. Mao, D., Epple, H., Uthgenannt, B., Novack, D.V., and Faccio, R. (2006) PLCgamma2 regulates osteoclastogen-esis via its interaction with ITAM proteins and GAB2. J. Clin. Invest. 116, 2869-2879 (Pubitemid 44684472)
52. Kim, H., Kim, T., Jeong, B., Cho, I., Han, D., Takegahara, N., Negishi-Koga, T., Takayanagi, T., Lee, J.H., Sul, J., Prasad, V., Lee, S., and Choi, Y. (2013) Tmem64 Modulates calcium signaling during RANKL-mediated osteoclast differentiation. Cell Metabol. 5, 249-260
53. Takayanagi, H. (2009) Osteoimmunology and the effects of the immune system on bone. Nat. Rev. Rheumatol. 5, 667-676
54. Gravallese, E.M., Harada, Y., Wang, J.T., Gorn, A.H., Thornhill, T.S., and Goldring, S.R. (1998) Identification of cell types responsible for bone resorption in rheuma-toid arthritis and juvenile rheumatoid arthritis. Am. J. Pathol. 152, 943-951 (Pubitemid 28173356)
55. Takayanagi, H., Oda, H., Yamamoto, S., Kawaguchi, H., Tanaka, S., Nishikawa, T., and Koshihara, Y. (1997) A new mechanism of bone destruction in rheuma-toid arthritis: synovial fibroblasts induce osteoclastogen-esis. Biochem. Biophys. Res. Commun. 240, 279-286 (Pubitemid 27523651)
56. Takayanagi, H., Iizuka, H., Juji, T., Nakagawa, T., Yamamoto, A., Miyazaki, T., Koshihara, Y., Oda, H., Nakamura, K., and Tanaka, S. (2000) Involvement of receptor activator ofnuclear factor kappa B ligand/osteo-clast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum. 43, 259-269 (Pubitemid 30395733)
57. Gravallese, E.M., Manning, C., Tsay, A., Naito, A., Pan, C., Amento, E., and Goldring, S.R. (2000) Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum. 43, 250-258 (Pubitemid 30395732)
58. Horwood, N.J., Kartsogiannis, V., Quinn, J.M., Romas, E., Martin, T.J., and Gillespie, M.T. (1999) Activated T lymphocytes support osteoclast formation in vitro. Biochem. Biophys. Res. Commun. 265, 144-150
59. Kotake, S., Udagawa, N., Hakoda, M., Mogi, M., Yano, K., Tsuda, E., Takahashi, K., Furuya, T., Ishiyama, S., Kim, K.J., Saito, S., Nishikawa, T., Takahashi, N., Togari, A., Tomatsu, T., Suda, T., and Kamatani, N. (2001) Activated human T cells directly induce osteoclas-togenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum. 44, 1003-1012 (Pubitemid 32433604)
60. Weitzmann, M.N., Cenci, S., Rifas, L., Haug, J., Dipersio, J., and Pacifici, R. (2001) T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappa B ligand-dependent and-independent mech-anisms. J. Bone Miner. Res. 16, 328-337 (Pubitemid 32105414)
61. Wang, R., Zhang, L., Zhang, X., Moreno, J., Celluzzi, C., Tondravi, M., and Shi, Y. (2002) Regulation of acti-vation-induced receptor activator of NF-kappa B ligand (RANKL) expression in T cells. Eur. J. Immunol. 32, 1090-1098 (Pubitemid 34428825)
62. Takayanagi, H., Ogasawara, K., Hida, S., Chiba, T., Murata, S., Sato, K., Takaoka, A., Yokochi, T., Oda, H., Tanaka, K., Nakamura, K., and Taniguchi, T. (2000) T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 408, 600-605
63. Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., Cua, D.J., and Takayanagi, H. (2006) Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203, 2673-2682 (Pubitemid 44833343)
64. Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S., Inoue, K., Kamatani, N., Gillespie, M.T., Martin, T.J., and Suda, T. (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 103, 1345-1352 (Pubitemid 29218305)
65. Weaver, C.T., Harrington, L.E., Mangan, P.R., Gavrieli, M., and Murphy, K.M. (2006) Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24, 677-688 (Pubitemid 43867371)
66. Iwakura, Y. and Ishigame, H. (2006) The IL-23/IL-17 axis in inflammation. J. Clin. Invest. 116, 1218-1222
67. H17 cells in chronic inflammation. Nat. Rev. Drug Discov. 11, 763-776
68. Nishihara, M., Ogura, H., Ueda, N., Tsuruoka, M., Kitabayashi, C., Tsuji, F., Aono, H., Ishihara, K., Huseby, E., Betz, U.A., Murakami, M., and Hirano, T. (2007) IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state. Int. Immunol. 19, 695-702 (Pubitemid 47078714)
69. Nardelli, D.T., Burchill, M.A., England, D.M., Torrealba, J., Callister, S.M., and Schell, R.F. (2004) Association of CD4+ CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody. Clin. Diagn. Lab. Immunol. 11, 1075-1084 (Pubitemid 39540847)
70. Frey, O., Petrow, P.K., Gajda, M., Siegmund, K., Huehn, J., Scheffold, A., Hamann, A., Radbruch, A., and Brauer, R. (2005) The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells. Arthritis Res. Ther. 7, R291-R301
71. Zaiss, M.M., Axmann, R., Zwerina, J., Polzer, K., Guckel, E., Skapenko, A., Schulze-Koops, H., Horwood, N., Cope, A., and Schett, G (2007) Treg cells suppress osteoclast formation: a new link between the immune system and bone. Arthritis Rheum. 56, 4104-4112 (Pubitemid 350262338)
72. Theill, L.E., Boyle, W.J., and Penninger, J.M. (2002) RANK-L and RANK: T cells, bone loss, and mamma-lian evolution. Annu. Rev. Immunol. 20, 795-823 (Pubitemid 34293440)
73. Palladino, M.A., Bahjat, F.R., Theodorakis, E.A., and Moldawer, L.L. (2003) Anti-TNF-alpha therapies: the next generation. Nat. Rev. Drug Discov. 2, 736-746
74. Diarra, D., Stolina, M., Polzer, K., Zwerina, J., Ominsky, M.S., Dwyer, D., Korb, A., Smolen, J., Hoffmann, M., Scheinecker, C., van der Heide, D., Landewe, R., Lacey, D., Richards, W.G., and Schett, G (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat. Med. 13, 156-163
75. Jones, D.H., Nakashima, T., Sanchez, O.H., Kozieradzki, I., Komarova, S.V., Sarosi, I., Morony, S., Rubin, E., Sarao, R., Hojilla, C.V., Komnenovic, V., Kong, Y.Y., Schreiber, M., Dixon, S.J., Sims, S.M., Khokha, R., Wada, T., and Penninger, J.M. (2006) Regulation of cancer cell migration and bone metastasis by RANKL. Nature 440, 692-696
76. Nishimoto, N. and Kishimoto, T. (2006) Interleukin 6: from bench to bedside. Nat. Clin. Pract. Rheumatol. 2, 619-626 (Pubitemid 44650950)
77. Mercier, F.E., Ragu, C., and Scadden, D.T. (2011) The bone marrow at the crossroads of blood and immunity. Nat. Rev. Immunol. 12, 49-60
78. Calvi, L.M., Adams, G.B., Weibrecht, K.W., Weber, J.M., Olson, D.P., Knight, M.C., Martin, R.P., Schipani, E., Divieti, P., Bringhurst, F.R., Milner, L.A., Kronenberg, H.M., and Scadden, D.T. (2003) Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425, 841-846 (Pubitemid 37351468)
79. Zhang, J., Niu, C., Ye, L., Huang, H., He, X., Tong, W.G., Ross, J., Haug, J., Johnson, T., Feng, J.Q., Harris, S., Wiedemann, L.M., Mishina, Y., and Li, L. (2003) Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425, 836-841 (Pubitemid 37351467)
80. Arai, F., Hirao, A., Ohmura, M., Sato, H., Matsuoka, S., Takubo, K., Ito, K., Koh, G.Y., and Suda, T. (2004) Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118, 149-161 (Pubitemid 38962572)
81. Kiel, M.J., Radice, G.L., and Morrison, S.J. (2007) Lack of evidence that hematopoietic stem cells depend on N-cadherin-mediated adhesion to osteoblasts for their maintenance. Cell Stem Cell 1, 204-217 (Pubitemid 47215590)
82. Lymperi, S., Horwood, N., Marley, S., Gordon, M.Y., Cope, A.P., and Dazzi, F. (2008) Strontium can increase some osteoblasts without increasing hematopoietic stem cells. Blood111, 1173-1181 (Pubitemid 351213398)
83. Ding, L., Saunders, T.L., Enikolopov, G., and Morrison, S.J. (2012) Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 481, 457-462
84. Omatsu, Y., Sugiyama, T., Kohara, H., Kondoh, G., Fujii, N., Kohno, K., and Nagasawa, T. (2010) The es-sential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity 33, 387-399
85. Yamazaki, S., Ema, H., Karlsson, G., Yamaguchi, T., Miyoshi, H., Shioda, S., Taketo, M.M., Karlsson, S., Iwama, A., and Nakauchi, H. (2011) Nonmyelinating Schwann cells maintain hematopoietic stem cell hiberna-tion in the bone marrow niche. Cell 147, 1146-1158
86. Mendez-Ferrer, S., Michurina, T.V., Ferraro, F., Mazloom, A.R., Macarthur, B.D., Lira, S.A., Scadden, D.T., Ma'ayan, A., Enikolopov, G.N., and Frenette, P.S. (2010) Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466, 829-834